(3S,10R,13S,16R)-N-[4-(hydroxyamino)-4-oxobutyl]-2,8,12,15-tetraoxo-13-propan-2-yl-1,7,11,14-tetrazatricyclo[14.3.0.03,7]nonadecane-10-carboxamide

C23H36N6O7 — CID 127027813

IUPAC(3S,10R,13S,16R)-N-[4-(hydroxyamino)-4-oxobutyl]-2,8,12,15-tetraoxo-13-propan-2-yl-1,7,11,14-tetrazatricyclo[14.3.0.03,7]nonadecane-10-carboxamide
SMILESCC(C)[C@@H]1NC(=O)[C@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)C[C@H](C(=O)NCCCC(=O)NO)NC1=O
InChIInChI=1S/C23H36N6O7/c1-13(2)19-22(34)25-14(20(32)24-9-3-8-17(30)27-36)12-18(31)28-10-5-7-16(28)23(35)29-11-4-6-15(29)21(33)26-19/h13-16,19,36H,3-12H2,1-2H3,(H,24,32)(H,25,34)(H,26,33)(H,27,30)/t14-,15-,16+,19+/m1/s1
InChIKeyKEGNHRHLBGEVRZ-JEWRLFTDSA-N
MW508.58 g/mol
LogP-1.60
Rot. Bonds6

About (3S,10R,13S,16R)-N-[4-(hydroxyamino)-4-oxobutyl]-2,8,12,15-tetraoxo-13-propan-2-yl-1,7,11,14-tetrazatricyclo[14.3.0.03,7]nonadecane-10-carboxamide

(3S,10R,13S,16R)-N-[4-(hydroxyamino)-4-oxobutyl]-2,8,12,15-tetraoxo-13-propan-2-yl-1,7,11,14-tetrazatricyclo[14.3.0.03,7]nonadecane-10-carboxamide (PubChem CID 127027813) has the molecular formula C23H36N6O7 and a molecular weight of 508.58 g/mol. Its IUPAC name is (3S,10R,13S,16R)-N-[4-(hydroxyamino)-4-oxobutyl]-2,8,12,15-tetraoxo-13-propan-2-yl-1,7,11,14-tetrazatricyclo[14.3.0.03,7]nonadecane-10-carboxamide.

Molecular Properties

Compound Name(3S,10R,13S,16R)-N-[4-(hydroxyamino)-4-oxobutyl]-2,8,12,15-tetraoxo-13-propan-2-yl-1,7,11,14-tetrazatricyclo[14.3.0.03,7]nonadecane-10-carboxamide
PubChem CID127027813
Molecular FormulaC23H36N6O7
Molecular Weight508.58 g/mol
Exact Mass508.26
IUPAC Name(3S,10R,13S,16R)-N-[4-(hydroxyamino)-4-oxobutyl]-2,8,12,15-tetraoxo-13-propan-2-yl-1,7,11,14-tetrazatricyclo[14.3.0.03,7]nonadecane-10-carboxamide
SMILESCC(C)[C@@H]1NC(=O)[C@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)C[C@H](C(=O)NCCCC(=O)NO)NC1=O
InChIInChI=1S/C23H36N6O7/c1-13(2)19-22(34)25-14(20(32)24-9-3-8-17(30)27-36)12-18(31)28-10-5-7-16(28)23(35)29-11-4-6-15(29)21(33)26-19/h13-16,19,36H,3-12H2,1-2H3,(H,24,32)(H,25,34)(H,26,33)(H,27,30)/t14-,15-,16+,19+/m1/s1
InChIKeyKEGNHRHLBGEVRZ-JEWRLFTDSA-N
XLogP-1.60
TPSA177.25 Ų
H-Bond Donors5
H-Bond Acceptors7
Rotatable Bonds6
Heavy Atoms36
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500508.58
LogP ≤ 5-1.60
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze (3S,10R,13S,16R)-N-[4-(hydroxyamino)-4-oxobutyl]-2,8,12,15-tetraoxo-13-propan-2-yl-1,7,11,14-tetrazatricyclo[14.3.0.03,7]nonadecane-10-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Tasidotin Hydrochloride
CID 11479259
Tasidotin
CID 9895066
H-DL-Pyr-DL-Leu-DL-Leu-DL-Pro-NH2
CID 3103042
(2R,3S)-N-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-N'-hydroxy-2-(2-methylpropyl)-3-pyrrolidin-1-ylbutanediamide
CID 10572102
H-Leu-Asp(1)-N(1)Gly-NHOH.HCl
CID 44478564
H-aIle-Asp(1)-N(1)Gly-NHOH.HCl
CID 44478566
H-Pro-Asp(1)-N(1)Gly-NHOH.HCl
CID 57402635
Ac-Leu-Pro-Ile-Dap-Ile-Pro-Leu-NMe2
CID 145965634
5-Oxo-L-prolyl-L-leucyl-L-prolinamide
CID 191115
(2S)-N1-[2-(Hydroxyamino)-2-oxoethyl]-N1,N2-bis(3-methylbutyl)-1,2-pyrrolidinedicarboxamide
CID 59908776
(3R,10S,13S,16S)-N-[4-(hydroxyamino)-4-oxobutyl]-2,8,12,15-tetraoxo-13-propan-2-yl-1,7,11,14-tetrazatricyclo[14.3.0.03,7]nonadecane-10-carboxamide
CID 127027808
5-Oxo-L-prolyl-D-leucyl-L-prolinamide
CID 13312501

Frequently Asked Questions

What is the IUPAC name of (3S,10R,13S,16R)-N-[4-(hydroxyamino)-4-oxobutyl]-2,8,12,15-tetraoxo-13-propan-2-yl-1,7,11,14-tetrazatricyclo[14.3.0.03,7]nonadecane-10-carboxamide?
The IUPAC name of (3S,10R,13S,16R)-N-[4-(hydroxyamino)-4-oxobutyl]-2,8,12,15-tetraoxo-13-propan-2-yl-1,7,11,14-tetrazatricyclo[14.3.0.03,7]nonadecane-10-carboxamide (CID 127027813) is (3S,10R,13S,16R)-N-[4-(hydroxyamino)-4-oxobutyl]-2,8,12,15-tetraoxo-13-propan-2-yl-1,7,11,14-tetrazatricyclo[14.3.0.03,7]nonadecane-10-carboxamide.
What is the SMILES notation for (3S,10R,13S,16R)-N-[4-(hydroxyamino)-4-oxobutyl]-2,8,12,15-tetraoxo-13-propan-2-yl-1,7,11,14-tetrazatricyclo[14.3.0.03,7]nonadecane-10-carboxamide?
The canonical SMILES for (3S,10R,13S,16R)-N-[4-(hydroxyamino)-4-oxobutyl]-2,8,12,15-tetraoxo-13-propan-2-yl-1,7,11,14-tetrazatricyclo[14.3.0.03,7]nonadecane-10-carboxamide is CC(C)[C@@H]1NC(=O)[C@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)C[C@H](C(=O)NCCCC(=O)NO)NC1=O.
What is the InChIKey of (3S,10R,13S,16R)-N-[4-(hydroxyamino)-4-oxobutyl]-2,8,12,15-tetraoxo-13-propan-2-yl-1,7,11,14-tetrazatricyclo[14.3.0.03,7]nonadecane-10-carboxamide?
The InChIKey is KEGNHRHLBGEVRZ-JEWRLFTDSA-N. The full InChI is InChI=1S/C23H36N6O7/c1-13(2)19-22(34)25-14(20(32)24-9-3-8-17(30)27-36)12-18(31)28-10-5-7-16(28)23(35)29-11-4-6-15(29)21(33)26-19/h13-16,19,36H,3-12H2,1-2H3,(H,24,32)(H,25,34)(H,26,33)(H,27,30)/t14-,15-,16+,19+/m1/s1.
What are the key properties of (3S,10R,13S,16R)-N-[4-(hydroxyamino)-4-oxobutyl]-2,8,12,15-tetraoxo-13-propan-2-yl-1,7,11,14-tetrazatricyclo[14.3.0.03,7]nonadecane-10-carboxamide?
(3S,10R,13S,16R)-N-[4-(hydroxyamino)-4-oxobutyl]-2,8,12,15-tetraoxo-13-propan-2-yl-1,7,11,14-tetrazatricyclo[14.3.0.03,7]nonadecane-10-carboxamide has a molecular weight of 508.58 g/mol, XLogP of -1.60, 6 rotatable bonds, 5 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,10R,13S,16R)-N-[4-(hydroxyamino)-4-oxobutyl]-2,8,12,15-tetraoxo-13-propan-2-yl-1,7,11,14-tetrazatricyclo[14.3.0.03,7]nonadecane-10-carboxamide is sourced from PubChem (CID 127027813), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).